The website of Pathology In Practice Magazine

CHOSOURCE: a platform for COVID-19-related therapeutics and diagnostics

Horizon Discovery Group has announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.

The CHOSOURCE platform includes a gene-edited glutamine synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line, a well-established GS expression system recognised in the industry and by regulators as suitable for high-yield biomanufacturing. The platform is already offered as a royalty-free alternative for the production of complex proteins and is empowering organisations from early-stage start-ups to large pharmaceutical companies to drive efficiencies throughout development and production. 

Horizon is already a key supplier for research relating to COVID-19, providing many tools and services to academia and industry to support efforts in addressing the pandemic. This offering extends Horizon’s COVID-19 support portfolio.

Jesús Zurdo (pictured), Global Head Bioprocessing, Horizon Discovery, said: “The current coronavirus crisis is highlighting existing shortcomings in the development of much-needed therapeutics. Horizon Discovery is fully committed to help innovators in their efforts to develop new solutions to tackle the COVID-19 pandemic. We are providing immediate access to our state-of-the-art bioproduction platform under very favourable terms to facilitate such efforts.”

https://horizondiscovery.com/en/products/covid19-research-support

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 14/06/2021 12:35:35 Step Communications Ltd. Registered in England. Registration Number 3893025